Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines

Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines

Bibliographic Details
Main Authors: Nacif Marcelo, Arai Andrew E, Lima Joao A, Bluemke David A
Format: Article
Language:English
Published: BMC 2012-02-01
Series:Journal of Cardiovascular Magnetic Resonance
id doaj-ac7b989126704d448641c6646b881e2e
record_format Article
spelling doaj-ac7b989126704d448641c6646b881e2e2020-11-25T02:13:58ZengBMCJournal of Cardiovascular Magnetic Resonance1097-66471532-429X2012-02-0114Suppl 1P4610.1186/1532-429X-14-S1-P46Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelinesNacif MarceloArai Andrew ELima Joao ABluemke David A
collection DOAJ
language English
format Article
sources DOAJ
author Nacif Marcelo
Arai Andrew E
Lima Joao A
Bluemke David A
spellingShingle Nacif Marcelo
Arai Andrew E
Lima Joao A
Bluemke David A
Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines
Journal of Cardiovascular Magnetic Resonance
author_facet Nacif Marcelo
Arai Andrew E
Lima Joao A
Bluemke David A
author_sort Nacif Marcelo
title Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines
title_short Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines
title_full Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines
title_fullStr Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines
title_full_unstemmed Gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines
title_sort gadolinium-enhanced cardiac magnetic resonance imaging: administered dose in relationship to united states food and drug administration (fda) guidelines
publisher BMC
series Journal of Cardiovascular Magnetic Resonance
issn 1097-6647
1532-429X
publishDate 2012-02-01
work_keys_str_mv AT nacifmarcelo gadoliniumenhancedcardiacmagneticresonanceimagingadministereddoseinrelationshiptounitedstatesfoodanddrugadministrationfdaguidelines
AT araiandrewe gadoliniumenhancedcardiacmagneticresonanceimagingadministereddoseinrelationshiptounitedstatesfoodanddrugadministrationfdaguidelines
AT limajoaoa gadoliniumenhancedcardiacmagneticresonanceimagingadministereddoseinrelationshiptounitedstatesfoodanddrugadministrationfdaguidelines
AT bluemkedavida gadoliniumenhancedcardiacmagneticresonanceimagingadministereddoseinrelationshiptounitedstatesfoodanddrugadministrationfdaguidelines
_version_ 1724902983701889024

Similar Items